TICKERNERD
Menu
LFMDLFMDHealthcare · Health Information Services

LFMD Stock Forecast: LifeMD, Inc. Price Predictions for 2026-2027

Last close, 18 Sept 2026
$3.22
+0.63% on the day

The 8 Wall Street analysts covering LifeMD, Inc. hold a median 12-month price target of $7.5 — +132.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 31 of 100 as at 19 Sept 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$155.2M
Ticker Nerd rank
31 / 100
Median analyst target
$7.50
Analysts covering
8
Revenue$47.3M−24.0% y/y
Operating income−$7.1M
Net income−$7.1M
Free cash flow−$8.6M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+5.6%
1M
−1.5%
YTD
−5.6%
1Y
−49.9%
From 52W high
−53.8%
From 52W low
+22.0%
$2.64
$6.97
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

LFMD stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores LifeMD, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 19 Sept 2026
31 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
82
Issuance
76
Size
71
Quality
55
Revisions
30
Value
27
Volatility
21
Growth
21
Momentum
10

Accruals (82): Reported profit is backed by cash, and the company is not expanding recklessly.

Momentum (10): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

LFMD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on LFMD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$2.00$4.00$6.00$8.00$10.00$12.00$14.00$16.00Oct 25Jan 26Apr 26Jul 26LFMDHigh $15.00Median $7.50Low $5.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says8 analysts
8 Buy0 Hold0 Sell
Low $5.00Median $7.50High $15.00

The green dot is the last close — the median target sits +132.9% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 1 moved their price target up and 3 moved it down.

DateFirmActionRatingTarget
17 Sept 2026HC Wainwright & Co.ReiteratesBuy$9.00
7 Aug 2026HC Wainwright & Co.MaintainsBuy$10 → $9.00
7 Aug 2026HC Wainwright & Co.MaintainsBuy—
6 Aug 2026B. Riley SecuritiesMaintainsBuy—
6 Aug 2026B. Riley SecuritiesMaintainsBuy$10 → $8.00
6 Aug 2026BTIGMaintainsBuy$10 → $9.00
6 Aug 2026BTIGMaintainsBuy—
26 May 2026HC Wainwright & Co.ReiteratesBuy$10
26 May 2026HC Wainwright & Co.ReiteratesBuy—
4 May 2026BTIGReiteratesBuy—
16 Mar 2026MizuhoUpgradeOutperform—
12 Mar 2026Freedom BrokerMaintainsBuy—
12 Mar 2026Freedom Capital MarketsMaintainsBuy$8.00 → $10
11 Mar 2026HC Wainwright & Co.MaintainsBuy—
10 Mar 2026BTIGReiteratesBuy—
24 Nov 2025Freedom BrokerMaintainsBuy—
19 Nov 2025HC Wainwright & Co.MaintainsBuy—
19 Nov 2025KeybancMaintainsOverweight—
19 Nov 2025MizuhoMaintainsNeutral—
18 Nov 2025B. Riley SecuritiesMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. LFMD appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

LFMD vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 18 Sept 2026, LifeMD, Inc. returned −49.9% against +16.3% for the S&P 500, dividends included.

LFMD vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120Oct 25Jan 26Apr 26Jul 26LFMDS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

LFMD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−222.2%
Analysts raising
0
Analysts cutting
1
Fundamentals

LifeMD, Inc. (LFMD) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
12.9×

Cheaper than 51% of US stocks

Price / sales
0.8×

Cheaper than 73% of US stocks

Price / book
19.3×

Cheaper than 5% of US stocks

EV / EBITDA
−7.2×

Cheaper than 82% of US stocks

Growth & margins
Revenue growth (YoY)
−3.5%

Higher than 22% of US stocks

Earnings growth (YoY)
−24.0%

Higher than 19% of US stocks

Gross margin
88.8%

Higher than 96% of US stocks

Operating margin
−15.1%

Higher than 23% of US stocks

Net margin
0.1%

Higher than 47% of US stocks

Returns & dividend
Return on equity
−515.9%

Higher than 3% of US stocks

Return on assets
−18.9%

Higher than 20% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

LifeMD, Inc. (LFMD) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • LifeMD, Inc. has a market value of $155.2M and an enterprise value of $136.1M.

  • Revenue in the twelve months to 30 June 2026: $164.7M. The latest quarter shrank 3.5% year on year.

  • Net income over the same four quarters: $430K, a 0.3% net margin.

  • Diluted earnings per share, trailing twelve months: $−0.05.

  • Free cash flow in the twelve months to 30 June 2026: −$18.3M, after $7.2M of capital spending.

  • LifeMD, Inc. spent $3.1M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 47.8M.

  • Trailing P/E: 12.9×; forward P/E: 8.5× — the forward figure prices analyst consensus estimates, not reported earnings.

  • LifeMD, Inc. employs 347 people — $475K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 20 Sept 2026

Data provided by Twelve Data

Peers

LFMD vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
LFMDLifeMD, Inc.$155.2M
31
DHDefinitive Healthcare Corp.$137.0M
77
OPRXOptimizeRx Corp.$135.3M
81
HCATHealth Catalyst, Inc.$134.7M
50
SPOKSpok Holdings, Inc.$214.0M
58
AMWLAmerican Well Corp.$227.6M
86
CCLDCareCloud, Inc.$92.2M
72

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own LifeMD, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest LFMD news & analysis

AT&T Teams Up With LifeMD for Virtual Health Care: Can it Aid Shares?

Zacks Investment Research · 16 Sept 2026positive

AT&T has teamed up with LifeMD to offer complimentary LifeMD memberships to AT&T customers, providing access to virtual care, prescriptions, and pharmacy services. The partnership expands AT&T's customer benefits through LifeMD's telehealth offerings.

Why it matters — A partnership with a major telecom such as AT&T could broaden LifeMD's exposure to a large customer base, potentially increasing adoption of its virtual care services.

LifeMD: Still Undervalued Despite Earnings Miss

Seeking Alpha · 16 Sept 2026positive

LifeMD reported disappointing Q2 2026 results, lowering its revenue and EBITDA guidance and posting a sequential subscriber decline. The company is shifting from auction-based marketing to partnerships with manufacturers, employers, and insurers to reduce customer acquisition costs, which currently stand at 59% of revenue.

Why it matters — LFMD watchers would care because high customer acquisition costs are pressuring EBITDA, and management's strategic shift toward partnerships could determine whether the profitable core model (88% gross margin) translates into sustained earnings.

AT&T Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMD

PRNewsWire · 15 Sept 2026positive

AT&T has announced an exclusive collaboration with LifeMD, becoming the first and only carrier to offer eligible wireless and fiber customers free access to a LifeMD membership, a $228 annual value, with on-demand access to the company's nationwide virtual care and pharmacy platform.

Why it matters — This exclusive partnership broadens LifeMD's distribution reach and exposure to a large carrier customer base, potentially expanding its user adoption.

LifeMD, Inc. (LFMD) Q2 2026 Earnings Call Transcript

Seeking Alpha · 6 Aug 2026neutral

LifeMD, Inc. held its Q2 2026 earnings call, and Seeking Alpha published the full transcript of the call. The transcript documents the company's earnings discussion for the second quarter of 2026.

Why it matters — A LifeMD watcher would use this transcript to review management's own commentary and Q2 2026 results directly from the source.

LifeMD Q2 Earnings Call Highlights

MarketBeat · 6 Aug 2026negative

LifeMD reported second-quarter revenue of $47.3 million, within its prior guidance range, while posting an adjusted EBITDA loss of approximately $3.5 million. Elevated customer acquisition costs and a lower introductory price for branded GLP-1 care pressured profitability.

Why it matters — The adjusted EBITDA loss and margin pressure signal that LifeMD's growth investments and GLP-1 pricing strategy are weighing on near-term profitability despite revenue meeting guidance.

FAQ

Frequently asked questions about LFMD stock

What is the LFMD stock price forecast for 2026-2027?

The 8 Wall Street analysts covering LifeMD, Inc. have a median 12-month price target of $7.5, with estimates ranging from $5 to $15. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is LFMD stock a buy right now?

Of the 8 analysts covering LifeMD, Inc., 8 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks LifeMD, Inc. 31 out of 100 across roughly 4,600 US stocks as at 19 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank LFMD?

As at 19 Sept 2026, LifeMD, Inc. ranks 31 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (82 of 100).

Will LFMD stock go up?

No one can know that. What the data says: the median 12-month target from 8 analysts implies +132.9% from the last close, and Ticker Nerd's factor model ranks LifeMD, Inc. 31 out of 100 as at 19 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the LFMD stock forecast for 2030?

No analyst covering LifeMD, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for LFMD are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $5 to $15 over the next 12 months.

How has LFMD stock performed over the past year?

LifeMD, Inc. returned -49.9% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does LifeMD, Inc. do?

LifeMD, Inc. is a direct-to-patient telehealth company that provides virtual medical care and pharmacy services across the United States.

What is the latest news on LFMD?

The most recent item we track (Zacks Investment Research, 16 Sept 2026): "AT&T Teams Up With LifeMD for Virtual Health Care: Can it Aid Shares?". AT&T has teamed up with LifeMD to offer complimentary LifeMD memberships to AT&T customers, providing access to virtual care, prescriptions, and pharmacy services. The partnership expands AT&T's customer benefits through LifeMD's telehealth offerings.

Company

About LifeMD, Inc.

LifeMD, Inc. is a direct-to-patient telehealth company that provides virtual medical care and pharmacy services across the United States. LifeMD’s platform connects patients with licensed healthcare providers for primary care, urgent care, and chronic care management, supported by digital prescribing, lab testing, and care coordination tools. The company also offers specialized consumer health brands focused on men’s health, hair loss, women’s health, allergy and asthma care, and other common conditions, along with related prescription and over-the-counter products. In addition, LifeMD serves patients through subscription and membership-based care models designed to make access to healthcare more convenient and streamlined. Headquartered in New York, LifeMD operates at the intersection of telehealth, pharmacy fulfillment, and digital healthcare services.

CEO Mr. Justin Schreiber · 347 employees · United States · https://lifemd.com